DEARGEN Trademark

Trademark Overview

On Monday, November 23, 2020, a trademark application was filed for DEARGEN with the United States Patent and Trademark Office. The USPTO has given the DEARGEN trademark a serial number of 90336147. The federal status of this trademark filing is REGISTERED as of Tuesday, January 24, 2023. This trademark is owned by DEARGEN INC.. The DEARGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

genetic testing for scientific research purposes; development of computer software systems for the storage of data; development of computer software systems for the transmission of data; development of computer software systems for the processing of data; database design and development; development of computer software for data processing; providing information relating to scientific analysis of the genetic information via online networks; biological information check being genetic testing for scientific research purposes; providing platform as a service (PaaS) services featuring computer software platforms for use in database management; platform as a service (PaaS) services featuring computer software platforms for use in drug development for use in prediction, identification or discovery of biological targets, molecular structures, drug binding affinity, drug absorption, drug distribution, drug metabolism, drug excretion and drug toxicity; software design and development; software ...
deargen

General Information

Serial Number90336147
Word MarkDEARGEN
Filing DateMonday, November 23, 2020
Status700 - REGISTERED
Status DateTuesday, January 24, 2023
Registration Number6965074
Registration DateTuesday, January 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements

Goods and Servicesgenetic testing for scientific research purposes; development of computer software systems for the storage of data; development of computer software systems for the transmission of data; development of computer software systems for the processing of data; database design and development; development of computer software for data processing; providing information relating to scientific analysis of the genetic information via online networks; biological information check being genetic testing for scientific research purposes; providing platform as a service (PaaS) services featuring computer software platforms for use in database management; platform as a service (PaaS) services featuring computer software platforms for use in drug development for use in prediction, identification or discovery of biological targets, molecular structures, drug binding affinity, drug absorption, drug distribution, drug metabolism, drug excretion and drug toxicity; software design and development; software engineering; development of pharmaceutical preparations and medicines; pharmaceutical research services; research relating to medicines being pharmaceutical research services; pharmaceutical drug development services; scientific research in the field of genetic engineering; scientific research in the field of gene analysis; scientific research for medical products; application service provider, namely, hosting computer application software for others in the field of knowledge management for creating searchable databases of information and data

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 28, 2021
Primary Code042
First Use Anywhere DateSaturday, January 8, 2022
First Use In Commerce DateSaturday, January 8, 2022

Trademark Owner History

Party NameDEARGEN INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDaejeon 34051
KR
Party NameDEARGEN INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDaejeon 34051
KR
Party NameDEARGEN INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDaejeon 34051
KR

Trademark Events

Event DateEvent Description
Thursday, August 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 24, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, December 17, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 16, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 15, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, December 2, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 2, 2022FINAL REFUSAL E-MAILED
Friday, December 2, 2022SU - FINAL REFUSAL - WRITTEN
Friday, October 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 19, 2022NON-FINAL ACTION E-MAILED
Friday, August 19, 2022SU - NON-FINAL ACTION - WRITTEN
Friday, July 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 23, 2022USE AMENDMENT FILED
Thursday, July 7, 2022SOU EXTENSION 1 GRANTED
Thursday, June 23, 2022SOU EXTENSION 1 FILED
Thursday, July 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 23, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 23, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 22, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, September 22, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 22, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, September 22, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, August 27, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 27, 2021FINAL REFUSAL E-MAILED
Friday, August 27, 2021FINAL REFUSAL WRITTEN
Monday, July 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 7, 2021NON-FINAL ACTION E-MAILED
Friday, May 7, 2021NON-FINAL ACTION WRITTEN
Friday, May 7, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 26, 2020NEW APPLICATION ENTERED

Related Keywords

deargen software drug development computer data genetic systems information scientific biological